Copy

Colleagues: Read on for the latest news and events, and keep up to date on all things DoM via Twitter, Facebook, and our website.

This week's grand rounds

September 30 @ 8:00-9:00 am

Long-Term Outcomes After Combat Injury

Presenter: Ian Stewart, MD, USAF, MC
U.S. Air Force physician
San Antonio Military Medical Center

Our Latest News

Stanford Health Care President & CEO to step down at the end of 2015

Amir Dan Rubin, after leading an array of highly recognized and innovative efforts at Stanford Health Care, is leaving to assume a new executive leadership role in the health care industry.

How much Bisphenol A is okay?

According to Jennifer Hartle’s paper, appearing today in the Journal of Exposure Science and Environmental Epidemiology, the question isn’t whether the kids are getting BPA in their meals — they are — but whether any of them are getting doses of BPA that could affect their long-term health.

MaryJeanne Oliva is the Department of Medicine’s Employee of the Month

“MaryJeanne is the glue that holds our program together.” With these words, Nigam Shah, MD, succinctly summarized the value of August’s Employee of the Month, MaryJeanne Oliva.

Early-career awards fast track researcher’s studies on poverty and health

Juggling her duties as a clinician and an instructor in family medicine, Rita Hamad is closer than ever to her goal of a research career, with the help of an early-career program and pilot grants.

Inaugural Medicine X | ED event kicks off with a call to redefine medical education

In a rousing address this morning to an eager crowd of hundreds, Stanford anesthesiologist Larry Chu, MD, kicked off the first annual Medicine X | ED conference with a call to redefine medical education as we know it.

5 Questions: Euan Ashley on diagnosing the undiagnosable

A national program to diagnose difficult-to-diagnose patients is taking root at Stanford under the guidance of heart specialist Euan Ashley.

Landmark report on diagnostic errors unveiled by Institute of Medicine

Most Americans will get at least one faulty diagnosis in their lifetime, sometimes with devastating consequences and “urgent change is warranted to address this challenge,” a panel of medical experts said Tuesday.

Envisioning personalized medicine and clinical trials in a dish

If he develops heart disease in the future, Joseph Wu envisions his physicians selecting the ideal medication for him by first testing drugs on his “mini-me” surrogates – dishes of beating heart cells created from his own stem cells.

Stanford unveils first PhD in Health Policy

The three women who are the first doctoral candidates in the School of Medicine’s new PhD in Health Policy program have one guiding belief: economics, decision science and data are now key to improving health care.

Launching an interactive cancer projects map: A collaborative approach to global cancer research and program development

Despite living in a connected world, many research projects are developed with a so-called “convenience bias,” resulting in partnerships based on existing professional networks and collaborations.

Upcoming Grand Rounds

October 7 @ 8:00-9:00 am

Ethical Issues at the End of Life

David Magnus, PhD is Thomas A. Raffin Professor of Medicine and Biomedical Ethics, and Professor of Pediatrics at Stanford University, and directs the Stanford Center for Biomedical Ethics.

October 14 @ 8:00-9:00 am

Amyloid: The Old and the New

Michaela Liedtke is an assistant professor of hematology at Stanford University. She received her medical degree from Medizinische Hochschule Hannover in Germany.

Department Events

September 29 @ 7:00-8:00 am

Oncology Morbidity, Mortality, and Improvement Conference

Oncology

September 29 @ 8:00–9:00 am

Pneumonia

Infectious Diseases Lecture Series

September 29 @ 12:00–1:00 pm

The State of the Future for Pediatric Pharmacogenomics and Genomic Medicine

Frontiers in Cardiovascular Science

September 30 @ 1:00–2:00 pm

Morbidity and Mortality

PCCM Clinical Conferences

September 30 @ 4:00–6:30 pm

Clinical Conference

Digestive Disease

September 30 @ 4:00–5:00 pm

Wisdom of the Crowd or Tyranny of the Mob? OrderRex—Data-Mining Electronic Health Records for Clinical Decision Support

Research in Progress

October 2 @ 7:00–8:00 am

GI Manifestations of HIV/AIDS

Fellows Didactic Lecture

October 2 @ 1:00–2:00 pm

Grand Rounds: Small Cell Lung Cancer

PCCM

Funding and Fellowship Opportunities
Announcements »

In the News

“In a first, a diabetes drug saves lives. But how?” - Results from clinical trails of Jardiance, a diabetes medication, suggest that the drug may also reduce patients’ risk of dying from heart disease. Bob Harrington provides comment.

Forbes


“FDA nominee Califf’s ties to drug makers worry some” - Robert Califf was recently nominated to be the commissioner of the FDA. Bob Harrington provides comment.

New York Times


“Verghese: #MedEd must restore 1:1 training at the bedside” - Technological advances threaten the human connection between doctors and patients. Abraham Verghese is quoted.

Wing of Zock


“Medicare’s pioneer ACOs see modest drop in low-value care” - A new study has found a modest reduction in the use of low-value services. Arnold Milstein is quoted.

Medscape


“Euan Ashley on the National Institutes of Health’s Undiagnosed Diseases Network and precision health” - In this interview, Euan Ashley discussed the National Institutes of Health’s Undiagnosed Diseases Network and precision health.

KGO-AM


“Precision Medicine Initiative should enroll anyone in U.S. willing to share data, working group tells NIH” - Russ Altman weighs in on the importance of the U.S. Government’s Precision Medicine Initiative.

Genome Web


Additional Coverage:
NIH.gov: "Faces of the Precision Medicine Initiative"

Connect With Us @StanfordDeptMed


Facebook Twitter DoM Website

View in browser | Contact Us | Unsubscribe